About this episode
In Part 1, we discussed patient drug information disclosure so individuals could make informed decisions. We also talked about pitfalls in the use of prescription medication. We wrap things up in Part 2 by discussing the pharmaceutical industry, drug prices, and the reasons why the U.S. healthcare system needs some improvements.
Get every episode summarized
Each time We’re Not Done with PB&J publishes, we email you a written briefing from the transcript — the topics, who appeared, and any specific claims, with the ad reads skipped.
Email me new episodesFree for 3 shows. No card needed.
Hosts & guests
No transcript yet
This episode has not been transcribed. Request it and it moves to the front of the queue.
More episodes
More from We’re Not Done with PB&J
Can You Hear What I Hear? Hearing Loss Can Happen to Anyone
We’re Not Done with PB&J
The Missing Link: Why Healthy Cells Thrive and Cancer Cells Survive
We’re Not Done with PB&J
Cancer - Your Battle Plan A and Battleplan B
We’re Not Done with PB&J
The Body as a Sacred Trust
We’re Not Done with PB&J